Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections HIV Post-Exposure Prophylaxis (PEP) Guidelines Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia
Respiratory syncytial virus (RSV) vaccine guideline statement Read More »
Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections HIV Post-Exposure Prophylaxis (PEP) Guidelines Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia Supportive non-directive counseling regarding reproductive choices, high risk prenatal care, modified management of labour and delivery, and postpartum
Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections Opportunistic Infections HIV Post-Exposure Prophylaxis (PEP) Guidelines Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia Provincial Best Practice in HIV Case Management Care of HIV Positive Pregnant Women and Interventions to
Provincial Best Practice in HIV Case Management Read More »
Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections HIV Post-Exposure Prophylaxis (HIV PEP) Pre-Exposure Prophylaxis (HIV PrEP) for the prevention of HIV acquisition in British Columbia What’s New in the Guidance for the Use of Pre-exposure Prophylaxis (PrEP) for the Prevention of HIV Acquisition in British Columbia (BC)
Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections HIV Post-Exposure Prophylaxis (PEP) Guidelines Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia For information on how to obtain medication for prevention of HIV infection following a high risk occupational or
HIV Post-Exposure Prophylaxis (PEP) Guidelines Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
